PATENT CLAIM ANALYSIS

Application Number: 16100062
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["514", "678000"]

Abstract:
The present invention provides methods for the treatment, amelioration, or prevention of a symptom of neuronal damage associated with cerebral ischemia comprising administering compositions comprising a compound of Formula I.

Claim (Index 24):
A method for treating and/or ameliorating a cerebral ischemic event in a mammalian subject in need of such treatment, comprising administering to the subject an effective amount of a composition comprising one or more compounds of Formula I: where R 1 , R 2 , and R 3  are independently of each other hydrogen, (C 1 -C 6 )alkyl, or (C 1 -C 6 )alkoxy; and m is an integer between 1 and 12, inclusive; or any stereoisomer, or mixture of stereoisomers thereof; with the proviso that said subject has not been administered a compound of Formula I within the month prior to the cerebral ischemic event.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 96.0
- Lexical Diversity: 1.17857
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15411861', '14233734', '14850855', '16040281', '10667280']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7593531145365816
- 35 USC 102 Novelty (BERT): 0.5001704675820015
- Combined Prediction Score: 0.7334348498411236
- Mean Citation Score: 225.580152
- Max Citation Score: 226.47397
- Similarity Product: 149.15836925160647

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test